D. E. Shaw & Co., L.P. 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:05 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | D. E. Shaw & Co., L.P. | 764,613 3.500% | 44,240 (+6.14%) | Filing |
| 2021-06-01 4:02 pm Purchase | 2021-05-20 | 13G | Viridian Therapeutics, Inc. VRDN | D. E. Shaw & Co., L.P. | 720,373 8.500% | 248,679 (+52.72%) | Filing |
| 2021-05-10 4:04 pm Purchase | 2021-04-29 | 13G | Viridian Therapeutics, Inc. VRDN | D. E. Shaw & Co., L.P. | 471,694 6.500% | 471,694 (New Position) | Filing |